HHS Public Access Author manuscript Author Manuscript

J Am Coll Cardiol. Author manuscript; available in PMC 2016 July 14. Published in final edited form as: J Am Coll Cardiol. 2015 September 15; 66(11): 1209–1220. doi:10.1016/j.jacc.2015.06.1334.

Revascularization in Patients with Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery

Author Manuscript

Sripal Bangalore, M.D., M.H.A., Yu Guo, M.A., Zaza Samadashvili, M.D., Saul Blecker, M.D., M.H.S., Jinfeng Xu, Ph.D., and Edward L. Hannan, Ph.D., M.S., M.S. New York University School of Medicine, New York, NY [SB, YG, SB, JX] School of Public Health, State University of New York at Albany, Albany, NY [ELH, ZS]

Abstract Background—Randomized trials of percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery have routinely excluded patients with chronic kidney disease (CKD). Objectives—To evaluate the outcomes with PCI vs. CABG in patients with CKD.

Author Manuscript

Methods—Patients with CKD (eGFR